This bill aims to regulate the distribution of opioid antagonists by the Michigan Department of Health and Human Services to certain individuals or governmental entities, with the goal of reducing opioid-related overdoses in the state. It defines key terms such as "opioid antagonist" and "opioid-related overdose," clarifying that an opioid antagonist is a drug approved by the FDA for emergency treatment of opioid overdoses.

The bill stipulates that when the department distributes opioid antagonists at no cost, recipients will have the flexibility to select the formulation, delivery device, method of administration, or dosage of the drug they receive. However, this choice is limited if it would jeopardize the department's ability to secure federal funding. The bill emphasizes the importance of tailored responses to the opioid crisis while ensuring compliance with federal regulations.